Across TCGA pan-cancer cohorts, PNPLA10P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of PNPLA10P’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where PNPLA10P RNA is repressed in tumor relative to normal tissue. In most cancer types PNPLA10P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
THCA are the cancer types where PNPLA10P tumor–normal differential expression is most reproducible.